Compositions comprising milk fat globules and methods of making same
US11298379B2 · kind B2 · utility
Inventor
Key dates
| Filing date | Jun 11, 2020 |
| Grant date | Apr 12, 2022 |
| Priority date | — |
| Expiry date | Jun 11, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions including anti-viral compositions, therapeutic compositions, sunscreen compositions, skin treatment compositions, anti-aging compositions, and methods of making the same, are provided. Each composition includes milk fat globules (MFG) and may contain one or more agents encapsulated by the MFG. The unique nature of MFG provides an intact mammalian membrane containing proteins, glycoproteins, and carbohydrates found in mammary cells. By treating an infected patient with MFG, the MFG serve as a surrogate cell and interact with enveloped viruses, such as the COVID-19 coronavirus, the Herpes virus, and the Epstein Barr Virus, rendering them non-infectious. MFG derived from mammals can also be used to deliver pharmaceutical materials into an animal body such that the pharmaceutical materials bypass the venous blood and enter directly into the animal's lymphatic system. MFG allow the delivery of materials orally that could not heretofore have been delivered efficiently.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.